Submitted by: Submitted by vasu123
Views: 10
Words: 1186
Pages: 5
Category: Business and Industry
Date Submitted: 04/11/2016 10:52 PM
Antihypertensive Therapeutics Market Size, Share, Trends, Company
Profiles, Demand, Insights, Analysis, Research, Report, Opportunities,
Segmentation and Forecast To 2020
Hypertension is a heart-related disease which results in elevated blood pressure in the arteries. It
is also known as arterial hypertension or high blood pressure. This disease occurs on account of
alcohol, smoking, obesity, and other genetic factors. Although, the disease can be treated with a
healthy diet and exercise, antihypertensives are recommended to control it.
Antihypertensives are a class of drugs which can prevent hypertension and other cardiovascularrelated disorders like strokes and myocardial infarction. They are likely to reduce the heart
conditions by 21%. Beta blockers, thiazide diuretics, ACE inhibitors, calcium channel blockers,
and angiotensin II receptor antagonists (ARBs) are the different types of antihypertensive
therapeutics in major developed markets.
Thiazide diuretics aid in reducing salt and water from the kidneys. They are the first drugs to be
administered for a patient undergoing hypertension treatment. ACE inhibitors reduce serum
creatinine levels better than beta blockers. They are considered the first line of defense against
heart-related disorders. ARBs reduces the risko f myocardial infarction when combined with
amlodipine. Beta blockers are considered risky and can lead to strokes or type-2 diabetes.
However, they prevent heart attacks in persons who have already experienced a heart attack.
To Get More Details @ http://www.radiantinsights.com/research/antihypertensivetherapeutics-in-major-developed-markets-to-2020-increased-uptake-of-combinationtherapies-to-offset-effects-of-key-patent-expiries
The hypertension market was estimated to have earned USD 40 billion of revenue in 2013. The
market will attain USD 37 billion by 2020, owing to the patent expiry of major drugs. It is
predicted to grow at a 2.6% CAGR during the period of 2014 to 2017. The market will...